Antihaemophilic Factor -

AHF is primarily indicated for patients with congenital Factor VIII deficiency (Hemophilia A) and occasionally for .

Modern medicine offers two main types of factor replacement: highlights of prescribing information antihaemophilic factor

Regularly scheduled infusions (often 3 times per week) to prevent spontaneous bleeding and reduce long-term joint damage. AHF is primarily indicated for patients with congenital

Administered before and after surgery (perioperative management) to ensure safe clotting during the procedure. Types of AHF Products antihaemophilic factor

Used "on-demand" to stop active bleeding episodes from trauma or injury.